{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:06:54Z","timestamp":1784549214174,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.rpth.2026.106639","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:27:40Z","timestamp":1778578060000},"page":"106639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential expression of miR-128 in memory T cells of patients with severe hemophilia A with and without inhibitors"],"prefix":"10.1016","volume":"10","author":[{"given":"Silvia","family":"Spena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Pappalardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calogero C.","family":"Tedesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Gualtierotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7423-9864","authenticated-orcid":false,"given":"Flora","family":"Peyvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.106639_bib1","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM200106073442307","article-title":"The hemophilias\u2014from royal genes to gene therapy","volume":"344","author":"Mannucci","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.106639_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0140-6736(15)01123-X","article-title":"The past and future of haemophilia: diagnosis, treatments, and its complications","volume":"388","author":"Peyvandi","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2026.106639_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/2040620712464509","article-title":"Factor VIII inhibitors in hemophilia A: rationale and latest evidence","volume":"4","author":"Witmer","year":"2013","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.rpth.2026.106639_bib4","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1182\/bloodadvances.2019000650","article-title":"Induction of activated T follicular helper cells is critical for anti-FVIII inhibitor development in hemophilia A mice","volume":"3","author":"Jing","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2026.106639_bib5","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/jth.13961","article-title":"Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement","volume":"16","author":"Spena","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"Suppl 6","key":"10.1016\/j.rpth.2026.106639_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2516.2006.01361.x","article-title":"Genetic risk factors for inhibitors to factors VIII and IX","volume":"12","author":"Oldenburg","year":"2006","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.106639_bib7","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1182\/blood-2011-09-379453","article-title":"F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis","volume":"119","author":"Gouw","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106639_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12033-007-9013-8","article-title":"The microRNA (miRNA): overview of the RNA genes that modulate gene function","volume":"38","author":"Ying","year":"2008","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.rpth.2026.106639_bib9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of microRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.rpth.2026.106639_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102141","article-title":"MiR-128-3p\u2014a gray eminence of the human central nervous system","volume":"35","author":"Kiel","year":"2024","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.rpth.2026.106639_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154705","article-title":"Exploring the impact of miR-128 in inflammatory diseases: a comprehensive study on autoimmune diseases","volume":"248","author":"Margiana","year":"2023","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.rpth.2026.106639_bib12","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180540","article-title":"Decreased MiR-128-3p alleviates the progression of rheumatoid arthritis by up-regulating the expression of TNFAIP3","volume":"38","author":"Xia","year":"2018","journal-title":"Biosci Rep"},{"key":"10.1016\/j.rpth.2026.106639_bib13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neurobiolaging.2013.08.003","article-title":"miR128 up-regulation correlates with impaired amyloid \u03b2(1-42) degradation in monocytes from patients with sporadic Alzheimer\u2019s disease","volume":"35","author":"Tiribuzi","year":"2014","journal-title":"Neurobiol Aging"},{"issue":"Pt 12","key":"10.1016\/j.rpth.2026.106639_bib14","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1093\/brain\/awr262","article-title":"Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity","volume":"134","author":"Guerau-de-Arellano","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.rpth.2026.106639_bib15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-0037-1613214","article-title":"A 4% solution of bovine serum albumin can be used in place of factor VIII:C deficient plasma in the control sample in the Nijmegen Modification of the Bethesda factor VIII:C inhibitor assay","volume":"88","author":"Verbruggen","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106639_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.thromres.2018.05.027","article-title":"Risk factors for inhibitor development in severe hemophilia A","volume":"168","author":"Garagiola","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.106639_bib17","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nri3494","article-title":"MicroRNA-mediated regulation of T helper cell differentiation and plasticity","volume":"13","author":"Baumjohann","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.rpth.2026.106639_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132433","article-title":"Small ncRNA expression-profiling of blood from hemophilia A patients identifies miR-1246 as a potential regulator of factor 8 gene","volume":"10","author":"Sarachana","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2026.106639_bib19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.imlet.2012.02.014","article-title":"Identification of microRNA transcriptome involved in human natural killer cell activation","volume":"143","author":"Liu","year":"2012","journal-title":"Immunol Lett"},{"key":"10.1016\/j.rpth.2026.106639_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010724","article-title":"microRNA expression patterns reveal differential expression of target genes with age","volume":"5","author":"Noren Hooten","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2026.106639_bib21","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jtha.2022.12.017","article-title":"Race, ethnicity, F8 variants, and inhibitor risk: analysis of the \u201cMy Life Our Future\u201d hemophilia A database","volume":"21","author":"Ahmed","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106639_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2025.578531","article-title":"MicroRNA signatures of CD4+ T cell subsets in healthy and multiple sclerosis subjects determined by small RNA-sequencing","volume":"401","author":"Culina","year":"2025","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.rpth.2026.106639_bib23","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.4049\/jimmunol.177.11.7656","article-title":"Regulation of Th2 cell development by Polycomb group gene bmi-1 through the stabilization of GATA3","volume":"177","author":"Hosokawa","year":"2006","journal-title":"J Immunol"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926032978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926032978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:25:17Z","timestamp":1784546717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926032978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2475037926032978"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106639","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential expression of miR-128 in memory T cells of patients with severe hemophilia A with and without inhibitors","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106639","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"106639"}}